Skip to main content
Journal of Ophthalmic Inflammation and Infection
Download PDF
  • Original research
  • Open access
  • Published:

Prevention of Bacterial Biofilm Formation on Soft Contact Lenses Using Natural Compounds

Journal of Ophthalmic Inflammation and Infection volume 7, Article number: 11 (2017) Cite this article

Abstract

Purpose

In eye care field, contact lenses (CL) have a great impact on improving vision, but their use can be limited by ocular infection. CL- associated infections can be reduced by good attention to CL storage case practice. CL-care solutions should be able to control microbial growth on CL.

The aim of the study was to evaluate and compare the efficacy of CL-care solutions (found in Egyptian market) with some natural compounds in removal and inhibition of bacterial biofilm formed on soft CL.

Clinical isolates were recovered from patients having conjunctivitis from Benha University Hospital and identified microbiologically. Quantification of biofilm was done using microtiter plate assay. Three multipurpose CL-care solutions were examined for their ability to remove and inhibit biofilm. Also four natural extracts having antibacterial activity and are safe on eye were tested for their anti-biofilm activity.

Results

The major bacterial isolates from eye infections were Pseudomonas aeruginosa (36%) and Staphylococcus spp. (37.8%). Only 33.3% of isolates showed ability to produce weak to moderate biofilm. The tested multi-purpose CL-care solutions showed moderate ability to remove preformed biofilm. Among the tested natural compounds, Calendula officinalis and Buddleja salviifolia extracts showed an excellent efficacy in inhibition of biofilm and also removal of preformed biofilm.

Conclusion

This study demonstrated that isolates from infected eye and CL-cases showed weak to moderate biofilm formation. Calendula officinalis and Buddleja salviifolia extracts showed excellent effect on inhibition and removal of biofilm, these extracts could be added into CL-care solutions which could markedly reduce eye-infections during CL-wear.

Introduction

The human's eye is protected by many factors that prevent ocular infections. However, in certain circumstances, microorganisms gain access to the eye causing variety of infections. The most common bacteria that can cause eye infections are Staphylococcus aureus, Sterptococcus pneumoniae, Pseudomonas aeruginosa, Hemophilus influenza and Klebsiella species [1].

In the eye care field, contact lenses (CL) have a great impact on improving vision, but their use can be limited by ocular infection. CL-wear is the most important risk factor for microbial infections. Wearers of soft lenses are at higher risk than other types of lenses [2]. Wearing contact lenses is associated with changes in the ocular microbiota, the microbiota of ocular conjunctiva was found to be similar to that of skin under the eye [3]. Gram-negative bacteria are the predominant cause of CL-related microbial keratitis with Pseudomonas spp. being the most commonly isolated organism [4,5,6,7], while Staphylococcus spp. and Serratia spp. come next [8, 9]. Infections are more likely if there is poor lens hygiene [10]. Microbial infections associated with use of CL may be considerably reduced by attention to risk factors related to CL storage case practice [11, 12]. It is essential that CL-care solutions should be able to sufficiently decrease the amount of pathogens in order to decrease the risk of CL-related infections [13]. In addition, some infectious ocular diseases are due to bacterial biofilm formation, biofilm is highly resistant to many antimicrobials [14, 15]. Hence, CL-care solutions should have ability to reduce or prevent biofilm formation on CL.

For a long time many people around the world have used plants for therapy. Recently the number of people using plant extracts for therapy increased and the numbers remain on the rise [16, 17]. Many natural compounds have been used to kill infectious pathogens, others were used for eye remedies because they are known to be safe on eye [18, 19]. For example, honey was used for treatment of CL induced corneal ulcer; and it shows high in vitro antibacterial activity against ocular isolates [20]. Moreover, honey exhibits anti-biofilm and anti-inflammatory properties, and thus becomes an interesting ophthalmologic agent [21]. The flowers of Calendula officinalis have a good antimicrobial and anti-biofilm activities [22, 23]. And owing to their anti-inflammatory and healing properties, C. officinalis extracts are applied externally to treat conjunctivitis [24]. Jasminum flowers has antibacterial and antifungal activities due to its essential oil content, also leaf extract of Jasminum was used in treatment in of inflamed eyes [25, 26]. Buddleja salviifolia leaves were used for treatment of eye infections by tribes in South Africa. The extract of Buddleja officinalis leaves was used for partial treatment for surface diseases of eyes, it also exhibited a broad spectrum antibacterial activity [27, 28].

The need to prevent, reduce, or eliminate microbial biofilm is becoming an important constraint. Strategies, such as coatings with anti-biofilm and developing anti-biofilm therapeutics, are promising avenues to reduce the risk of biofilm-associated ocular infection [29]. In the current study honey, jasmine oil, Calendula Officinalis petal extract and Buddleja salviifolia leaves extract were assessed for their activity on inhibition and removal of bacterial biofilm on microtiter plates and soft contact lenses in comparison to three multi-purpose CL-care solutions found in Egyptian market; Renu, Opti-free and Perfect care solutions.

Results

Identification of bacterial isolates

A total 111 isolates were recovered from 184 specimens, 81 isolates from clinical samples and 30 isolates from CL cases. The isolated organisms were identified using standard microbiological tests. Among the 111 isolates, 41 (36.9%) were Gram positive. including 22 (19.8%) S. aureus, 10 (9%) S. epidermidis and 9 (8.1%) S. saprophyticus. The seventy Gram negative isolates include, 40 (36%) P. aeruginosa, 9 (8.1%) K. pneumonia, 7 (6.3%) Serratia spp., 6 (5.4%) Moraxella catarralis, 6 (5.4%) M. lacunata, and only 2 (1.8%) E. coli (Table 1).

Table 1 The distribution of specimens and type of bacterial isolates
Full size table

Assessment of biofilm formation by spectrophotometric method

All isolates were tested for biofilm production. Only 12 isolates (10.8%) were moderate biofilm forming, 25 isolates (22.5%) were weak biofilm forming and 74 (66.6%) were non biofilm forming. Twenty two P. aeruginosa and eight S. aureus isolates were biofilm forming. Only four S. epidermidis, two S. saprophyticus and one K. pneumonia isolates were weak biofilm producers (Table 2).

Table 2 Distribution of biofilm forming isolates
Full size table

Effectiveness of disinfectant solutions and natural compounds on inhibition of biofilm

The MICs for the tested disinfectant solutions and natural compounds were determined by broth micro-dilution method against all biofilm forming isolates. The MIC90 for both Renu and Opti-free were 0.125 of their original concentration. While MIC90 of Perfect solution was 0.25 of its original concentration. The MIC90 for Honey, Calendula officinalis, Jasmine oil and Buddleja salviifolia extract were 125 μL/mL, 31.2 μL/mL, 15.6 μL/mL. 31.2 μL/mL, respectively.

Sub-MICs (½ and ¼ MIC) of disinfectants solutions were tested for biofilm inhibition capacity. In case of ½ MIC, Opti-free was able to prevent 72.97% of tested isolates from biofilm formation. Perfect solution prevents 67.56% of tested isolates, while Renu was able to prevent only 29.72% of tested isolates (Fig. 1).

Fig. 1
figure 1

Percentage of biofilm inhibition by screened CL-care solutions and natural compounds

Full size image

For natural compounds, \( \frac{1}{2},\kern0.5em \frac{1}{4} \), and \( \frac{1}{8} \) MIC of Honey were able to inhibit 86.5%, 75.7%, and 73% of tested isolates from biofilm production respectively. Also, \( \frac{1}{2},\kern0.5em \frac{1}{4} \), and \( \frac{1}{8} \) MIC of Calendula extract were able inhibit 100%, 100%, and 67.6% of tested isolates from biofilm production respectively. For Buddleja salviifolia extract, \( \frac{1}{2},\kern0.5em \frac{1}{4} \), and \( \frac{1}{8} \) MIC were able to inhibit 100%, 83.8%, and 83.8% of tested isolates from biofilm production, respectively. Finally, \( \frac{1}{2},\kern0.5em \frac{1}{4} \), and \( \frac{1}{8} \) MIC of Jasmine oil were able to inhibit 62.2%, 62.2%, and 40.5% of tested isolates from biofilm formation, respectively (Fig. 1).

Effectiveness of disinfectant solutions and natural compounds on removal of pre-formed biofilm

Different concentrations (8, 4, 2 fold MIC) of disinfectant solutions were tested for their biofilm removal effect. All CL-care solution showed low effect on removal of preformed biofilm. Eight fold MIC of Opti free solution is considered the best in removal of biofilm as it removed biofilm formed by 43.2% of isolates. While eight fold MIC of Renu solution was able to remove biofilm formed by 27% of tested isolates and reduced strength of biofilm from moderate to weak in 21.6% of isolates. Four fold MIC of both Perfect and Renu solutions were able to remove preformed biofilm by 24.3% of tested isolates (Fig. 2).

Fig. 2
figure 2

Percentage of biofilm removal by screened -care solutions and natural compounds

Full size image

The biofilm formed by tested organisms were also exposed to 8, 4 and 2 fold MIC of Jasmine oil, Calendula officinalis extract, and Buddleja salviifolia extract and to 4 and 2 fold MIC of Honey. For Honey 4 and 2 fold MIC were able to remove biofilm formed by 59.5% for both concentrations. For Calendula officinalis, 8, 4 and 2 fold MIC were able to remove biofilm formed by 62.2%, 62.2% and 54.1% respectively. Regarding Buddleja salviifolia, 8, 4 and 2 fold MIC were able to remove biofilm formed by 70.3%, 70.3% and 51.4%, respectively. Jasmine oil showed the least effect, 8, 4 and 2 MIC were able to remove biofilm formed by 18.9%, 13.5% and 10.8% of isolates, respectively (Fig. 2).

Effectiveness of Calendula and Buddleja extracts on inhibition of biofilm formation and removal of preformed biofilm on CL

For both Calendula extract and Buddleja extract, ½ and ¼ MIC were tested on biofilm forming S. aureus and P. aeruginosa isolates. For Calendula, ½ MIC was able to inhibit biofilm formation on CL for the two isolates but ¼ MIC inhibits P. aeruginosa and reduces the ability of S. aureus to form biofilm on CL. While ½ MIC and ¼ MIC of Buddleja were able to inhibit biofilm formation for the two isolates.

For both Calendula and Buddleja extracts, 4 and 8 fold of MIC were tested on biofilm forming S. aureus isolate and P. aeruginosa isolates. Four and eight MIC of Calendula were able to remove preformed biofilm on soft CL. Four and eight MIC of Buddleja salviifolia were able to remove preformed biofilm of S. aureus but it only weakens the biofilm formed by P. aeruginosa.

Discussion

The eye is protected by a number of natural defence mechanisms that reduce the eye infections. However many ocular infections are caused by the use of soft CL [30]. The current study aims to screen for the biofilm forming isolates from infected eyes and CL-cases and to evaluate the anti-biofilm activity of some natural compounds in comparison to three CL-care solutions.

In the present study P. aeruginosa was the most isolated organism from eye infection. It was recovered at a frequency of 37%, followed by S. aureus (24.7%) and Klebsiella spp. (11%). Previous studies recovered P. aeruginosa at lower frequencies ranging from 1.25 - 19% [1, 30, 31]. The percentage of S. aureus was slightly lower than the 32.3% reported previously [32], but quite similar to previous studies that recovered S. aureus at frequency of 22%, and 23.6% [31, 33].

The major isolates from CL-cases were P. aeruginosa, Serratia spp. and S. saprophyticus. P. aeruginosa was isolated in the highest frequency (33.3%) which agree with the results of previous reports [34, 35]. In current study Serratia was recovered only from CL-cases in a frequency of 23.3% which is also near to what reported previously [34, 35].

In this study, only P. aeruginosa, Staphylococcus spp and klebsiella spp were able to form weak to moderate biofilms. 55% of isolated P. aeruginosa were biofilm producer. A previous study reported lower percentage (33%) [36], while Oncel and his colleagues found similar result, where 60% of isolated P. aeruginosa formed biofilm [37]. In this study, 36.4% of isolated S. aureus were biofilm producer, which is lower than the 51.9% reported previously [30].

The biofilm forming isolates were exposed to sub-MIC concentrations of the three disinfectant solutions found in the Egyptian market to test their ability to inhibit biofilm formation. Our results showed that the three disinfectant solutions have moderate activity against biofilm removal without the rubbing step that is recommended by the manufacturer but some consumers did not comply with lens hygiene procedures [38]. It worth mentioning that the current study is the first to assess anti-biofilm properties of CL-care solutions found in the Egyptian market against bacterial biofilms grown on both polystyrene microtiter plates and soft CL.

Previous study reported that all the tested lens care solutions were effective against planktonic bacterial growth, and were ineffective against bacterial biofilm in vitro [39]. The ability of Renu and Opti-free solutions to remove biofilm formed on silicon hydrogel lenses was assessed previously, the results were unsatisfactory when steps of rubbing and rinsing of lenses were omitted [38].

The tested organisms were also exposed to sub-MIC concentrations of four natural compounds to evaluate their ability to inhibit and remove biofilm. Buddleja salviifolia and Calendula officinalis extracts showed the highest activity in inhibiting biofilm formation followed by honey then jasmine oil. Also Buddleja salviifolia and Calendula officinalis extracts have excellent effect on removal of preformed biofilm, while honey has moderate effect. It was reported previously that honey was able to penetrate biofilm formed K. pneumoniae and P. aeruginosa [40]. However in our study honey showed moderate activity in removal of biofilm when compared with other tested compounds. Although Jasmine oil showed low MIC (15.6 μL/mL) in our study, but it cannot be considered effective in removal of preformed biofilm.

The phytochemical composition, biological activity and safety of Calendula officinalis extracts are well documented [41,42,43]. The main active constituents in Calendula are terpenoids, flavonoids, coumarines, quinones and volatile oils [42]. It was previously reported that the extracts of Calendula officinalis decreased the adherence of bacteria on glass tubes, inhibited adhesion on polystyrene surface and caused biofilm detachment [24]. Regarding safety issue, acute toxicity studies in rats and mice indicate that the extract is relatively nontoxic. Minimal ocular irritation was seen with one formulation containing lipophilic extract of C officinal and no irritation with other extracts [43, 44].

Buddleja officinalis was used by Chinese Medicine and elsewhere to treat eye diseases, with flavonoids as its effective part [27]. Phytochemical analysis of Buddleja extracts identified polyphenols, flavonoids and phenylethanoid as major components [45, 46]. Buddleja showed antimicrobial activity against Bacillus subtilis, S. aureus, E. coli and K. pneumoniae supporting the traditional use of the plant in the treatment of eye infections [28]. In vivo studies in animal models showed that eye drops containing Buddleja can be used safely to treat dry eye [27, 47].

Conclusions

In conclusion, the previous studies supported the results of current study that tested natural compounds could be used as prophylactic agent to prevent ocular infections especially those caused by CL-wear. To our knowledge, the current study is the first to assess the anti-biofilm activity of both Buddleja salviifolia and Jasmine oil. Also it is the first description of a model that study the anti-biofilm activity of both Calendula officinalis extract and Buddleja salviifolia extract on soft CL. Our study showed that Calendula officinalis and Buddleja salviifolia extracts have excellent effect on inhibition of biofilm formation and removal of preformed biofilm which make them promising agents that can be added to new more effective CL-care solutions.

Material and methods

Bacterial isolation and identification

A total number of 184 specimens were collected, 116 samples were obtained from Ophthalmology Department in Benha Educational University Hospital, Benha, Egypt. While 68 specimens were collected from CL-cases of lenses users. The study was approved by the Ethical Committee of our university.

All specimens were taken by moistened sterile swab. The swabs were cultured on chocolate agar, blood agar and MacConkey agar, then incubated at 37 °C for 24 hours. Gram stained films were prepared from the isolated colonies. Standard Microbiological tests were also done to identify each isolate to the species level [48].

Screened compounds

Three soft CL-care solutions available in Egyptian market were tested: Renu Multi-purpose solution (Bausch and Lomb-IOM, Milan, Italy), Opti-free solution (Alcon Laboratories, Inc. Fort Worth, Texas, USA) and Perfect care protein remover (Orchidia Pharmaceutical Industries, El Obour, Egypt). Four natural compounds were also tested including honey, jasmine oil, leaves extract of Buddleja salviifolia and petal extract of Calendula officinalis. Honey was purchased from Isis Company (Cairo, Egypt), Jasmine oil, Buddleja salviifolia leaves extract and Calendula officinalis flowers extract were prepared by Morgan chemicals company (Cairo, Egypt), upon authors request. Jasmine oil was extracted from Jasminum officinale petals by hydro-distillation [49] The powdered Calendula officinalis flowers were subjected to extraction with ethanol using soxhlet apparatus as described previously [50] The powdered leaves of Buddleja salviifolia were extracted with 20% aqueous methanol as reported previously [28].

Detection of biofilm forming isolates

All isolates were screened for their ability to form biofilm by microtiter plate method with some modifications [51]. Overnight cultures of isolates from trypticase soya agar (TSA) plates were inoculated in tryptone soya broth (TSB), and the turbidity was adjusted to 0.5 McFarland. The suspension were further diluted 1:100 to obtain density of 105-106 cells/mL. Aliquots of 100 μL were distributed in 96-well microtiter plate containing 100 μL of TSB with 2% glucose (TSB-glu), negative control wells were included. The plates were incubated for 48 hours at 37 °C. The content of each tube was aspirated and then washed three times with phosphate buffered saline (PBS) to remove any non-adherent bacteria. 200 μL of 99% methanol was added to each well for 15 min to fix biofilm. The wells were decanted, left to dry, and stained with 200 μL of 2% Hucker Crystal Violet (CV) for another 15 min. Excess stain was rinsed off gently by water. The plates were air dried; the bound dye was solubilized with 200 μL of 33% (v/v) glacial acetic acid. The Optical Density (OD) was measured at 570 nm using spectrophotometer (UV-1800 Shimadzu, Japan). The test was made in triplicates. Based on the measured ODs, the tested isolates were classified into four categories; non-adherent, weakly adherent, moderately adherent, and strongly adherent [51].

Determination of minimum inhibitory concentration (MIC) of Screened compounds

The MICs of disinfectants (CL-care solutions and natural compounds) were determined by broth dilution method according to CLSI [52]. Colonies from biofilm forming isolates were touched with a sterile loop and transferred to Muller-Hinton broth (MHB), the turbidity was adjusted to 0.5 McFarland. The suspension was then diluted 1:100 in MHB.

Two fold serial dilutions of each disinfectant agent were prepared using microtiter plates, 100 μL of each dilution are placed in adjacent wells. 100 μL of prepared inoculum were added to each dilution, control wells were included. Plates were incubated at 37 °C for 18-20 hours. The MIC was taken as the lowest concentration of disinfectant which inhibits bacterial growth.

Effectiveness of screened compounds on inhibition of biofilm formation

Overnight cultures of isolates from TSA plates were inoculated in TSB and the turbidity was adjusted to 0.5 McFarland which was further diluted 1:100 to obtain density of 105-106 cells/mL. Aliquots of 100 μL were distributed in 96-well microtiter plate containing 100 μL of sub-MIC of tested disinfectants (1/2 and 1/4 and 1/8 MIC) and incubated in stationary conditions for 48 hours at 37 °C. The content of each well was aspirated, washed three times with PBS, fixed with 200 μL of 99% methanol for 15 min. Then, the wells were decanted, air dried, and stained with 200 μL of 2% CV for 15 min. Excess stain was rinsed off gently by water, the plates were air dried, and the bound dye was solubilized with 200 μL of 33% glacial acetic acid. The OD was measured using spectrophotometer and used to calculate the strength of biofilm [51].

The ability of disinfectant solution to inhibit biofilm formation on soft CL (Clear vision, Korea) was also tested using the same procedure with some modifications [53]. Pieces of soft CL were placed in each well; 200 μL of ethanol-acetone (80:20) was used for solubilization of biofilm. The optical density was determined at 630 nm. Each experiment was performed in three replicates.

Effectiveness of screened compounds on removal of preformed biofilm

Overnight cultures of isolates from TSA plates were inoculated in TSB. The turbidity was adjusted to 0.5 McFarland and then diluted to 1:100. Aliquots of 100 μL were distributed in 96-well microtitre plate containing 100 μL TSB-glu and incubated for 48 hours at 37 °C. The content of each well was aspirated, washed three times with sterile PBS; 200 μL of two fold serial dilutions of the tested compounds (starting from 8, 4 and 2 fold MIC) were added to each well then incubated for 24 hrs at 37 °C. The wells were decanted and washed three times with sterile PBS, fixed with 200 μL of 99% methanol, air dried, and stained for 15 min with 200 μL of 2% Hucker CV. Excess stain was rinsed by water, plates were air dried, dye was solubilized with 200 μL of 33% glacial acetic acid and OD of de-staining solution was measured using spectrophotometer [51].

For CL, The experiment was repeated with the same procedure with addition of pieces of CL in each well, and 200 μL of ethanol-acetone (80:20) was used for solubilisation of biofilm. The optical density was determined at 630 nm. Each experiment was performed in three replicates [53].

Abbreviations

Cl:

Contact lens

CV:

Crystal Violet

MIC:

minimum inhibitory concentration

OD:

Optical Density

References

  1. Bharathi MJ, Ramakrishnan R, Shivakumar C et al (2010) Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol 58(6):497–507

    Article  PubMed  PubMed Central  Google Scholar 

  2. Fleiszig SM, Evans DJ (2010) Pathogenesis of contact lens-associated microbial keratitis. Optom Vis Sci 87(4):225–232

    PubMed  PubMed Central  Google Scholar 

  3. Shin H, Price K, Albert L et al (2016) Changes in the Eye microbiota associated with contact lens wearing. mBio 7(2):e00198–16

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cheng KH, Leung SL, Hoekman HW et al (1999) Incidence of contact-lens associated microbial keratitis and its related morbidity. Lancet 354:181–185

    Article  CAS  PubMed  Google Scholar 

  5. Houang E, Lam D, Fan D et al (2001) Microbial keratitis in Hong Kong: relationship to climate, environment and contact lens disinfection. Transact R Soc Trop Med Hyg 95:361–367

    Article  CAS  Google Scholar 

  6. Lam DS, Houang E, Fan DS et al (2002) Incidence and risk factors from microbial keratitis in Hong Kong: comparison with Europe and North America. Eye (Lond) 16:608–618

    Article  CAS  Google Scholar 

  7. Dutta J, Tripathi S, Dutta PK (2012) Progress in antimicrobial activities of chitin, chitosan and its oligosaccharides: a systematic study needs for food applications. Food Sci Technol Int 18(1):3–34

    Article  CAS  PubMed  Google Scholar 

  8. Alexadrakis G, Alfonso EC, Miller D (2000) Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 107:1497–1502

    Article  Google Scholar 

  9. Willcox MD, Zhu H, Vijay AK (2012) Effect of a warming device on contact lens case contamination. Eye Contact Lens 38(6):394–399

    Article  PubMed  Google Scholar 

  10. Morgan PB, Efron N, Hill EA et al (2005) Incidence of keratitis of varying severity among contact lens wearers. Br J Ophthalmol 89:430–436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Dart JK, Stapleton F, Minassian D (1991) Contact lenses and other risk factors in microbial keratitis. Lancet 338(8768):650–3

    Article  CAS  PubMed  Google Scholar 

  12. Radford CF, Bacon AS, Dart JK (1995) Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. BMJ 310(6994):1567–1570

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hildebrandt C, Wagner D, Kohlmann T (2012) In-vitro analysis of the microbicidal activity of 6 contact lens care solutions. BMC Infect Dis 12:241. doi:10.1186/1471-2334-12-241

    Article  PubMed  PubMed Central  Google Scholar 

  14. Fulcher TP, Dart JK, McLaughlin-Borlace L et al (2001) Demonstration of biofilm in infectious crystalline keratopathy using ruthenium red and electron microscopy. Ophthalmology 108(6):1088–92

    Article  CAS  PubMed  Google Scholar 

  15. Rossetti S, D’Alessandro L, Pellegrino F et al (2012) The effect of ketorolac on biofilm of Staphylococcus epidermidis isolated from post-cataract endophthalmitis. J Ophthal Inflamm Infect 2:89–93

    Article  CAS  Google Scholar 

  16. Al-Snafi AE (2015) Therapeutic properties of medicinal plants: review of their antibacterial activity (part I). Int J Pharm Ther 6(3):137–158

    Google Scholar 

  17. Rafieian-Kopaei M (2012) Medicinal plants and the human needs. J Herb Med Plarmacol 1(1):1–2

    Google Scholar 

  18. Hammer KA, Carson CF, Riley TV (1999) Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 86:985–990

    Article  CAS  PubMed  Google Scholar 

  19. Biswas NR, Gupta SK, Das GK et al (2001) Evaluation of Ophthacare eye drops- A herbal formulation in the management of various ophthalmic disorders. Phytother Res 15:618–620

    Article  CAS  PubMed  Google Scholar 

  20. Cernak M, Majtanova N, Cernak A et al (2012) Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery. Phytother Res 26(4):613–616

    Article  CAS  PubMed  Google Scholar 

  21. Majtanova N, Vodrazkova E, Kurilova V et al (2015) Complementary treatment of contact lens-induced corneal ulcer using honey: a case report. Cont Lens Anterior Eye 38(1):61–63

    Article  PubMed  Google Scholar 

  22. Efstratiou E, Hussain AI, Nigam PS et al (2012) Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogens. Complement Ther Clin Pract 18(3):173–176

    Article  PubMed  Google Scholar 

  23. Ghaima KK, Rasheed SF, Ahmed EF (2013) Antibiofilm, antibacterial and antioxidant activities of water extract of Calendula officinalis flowers. IJBPR 4(7):465–470

    Google Scholar 

  24. Butnariu M, Coradini CZ (2012) Evaluation of biologically active compounds from Calendula officinalis flowers using spectrophotometry. Chem Cent J 6(1):35. doi:10.1186/1752-153X-6-35

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Rath CC, Devi S, Dash SK et al (2008) Antibacterial potential assessment of Jasmine essential oil against E. coli. Indian J Pharm Sci 70(2):238–241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Santhanam J, Abd Ghani FN, Basri DF (2014) Antifungal activity of Jasminum sambac against Malassezia sp. and Non-Malassezia sp. isolated from human skin samples. J Mycol. Article ID 359630, http://dx.doi.org/10.1155/2014/359630

  27. Peng QH, Yao XL, Wu QL et al (2008) Effects of extract of buddleja officinalis on prevention of dry eye in castrated rabbits. Zhonghua yan ke za zhi 44(11):1011–1019

    PubMed  Google Scholar 

  28. Pendota SC, Aderogba MA, Ndhlala AR et al (2013) Antimicrobial and acetylcholinesterase inhibitory activities of Buddleja salviifolia (L.) Lam. leaf extracts and isolated compounds. J Ethnopharmacol 148(2):515–520

    Article  CAS  PubMed  Google Scholar 

  29. Bispo PJM, Haas W, Gilmore MS (2015) Biofilms in Infections of the Eye. Pathogens 4(1):111–136

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hou W, Sun X, Wang Z et al (2012) Biofilm-Forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from Ocular Infections. Invest Ophthalmol Vis Sci 53:5624–5631

    Article  CAS  PubMed  Google Scholar 

  31. Rahman ZA, Harun A, Hasan H et al (2013) Ocular surface infections in north eastern state of malaysia: a 10-year review of bacterial isolates and antimicrobial susceptibility. Eye Contact Lens 39(5):355–60

    Article  PubMed  Google Scholar 

  32. Sherif ZH, Labib FM, Mahmoud AH et al (1976) Acute conjunctivitis in a rural Egyptian community. Bull Ophthalmol Soc Egypt 69(73):1–8

    CAS  PubMed  Google Scholar 

  33. Anagaw B, Biadglegne F, Belyhun Y et al (2011) Bacteriology of ocular infections and antibiotic susceptibility pattern in Gondar University Hospital, North West Ethiopia. Ethiop Med J 49(2):117–123

    PubMed  Google Scholar 

  34. Larkin DF, Kilvington S, Easty DL (1990) Contamination of contact lens storage cases by Acanthamoeba and bacteria. Br J Ophthalmol 74(3):133–135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gray TB, Cursons RTM, Sherwan JF et al (1995) Acanthamoeba, bacterial, and fungal contamination of contact lens storage cases. Br J Ophthalmol 79:601–605

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Coban AY, Ciftci A, Onuk EE et al (2009) Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis. Mikrobiyol Bul 43(4):563–573

    CAS  PubMed  Google Scholar 

  37. Oncel S, Pinar E, Sener G et al (2010) Evaluation of bacterial biofilms in chronic rhinosinusitis. J Otolaryngol Head Neck Surg 39(1):52–55

    PubMed  Google Scholar 

  38. Kilvington S, Lonnen J (2009) A comparison of regimen methods for the removal and inactivation of bacteria, fungi and Acanthamoeba from two types of silicon hydrogel lenses. Cont Lens Anterior Eye 32:73–77

    Article  PubMed  Google Scholar 

  39. Szczotka-Flynn LB, Imamura Y, Chandra J et al (2009) Increased resistance of contact lens related bacterial biofilms to antimicrobial activity of soft contact lens care solutions. Cornea 28(8):918–926

    Article  PubMed  PubMed Central  Google Scholar 

  40. Merckoll P, Jonassen T, Vad ME et al (2009) Bacteria, biofilm and honey: a study of the effects of honey on ‘planktonic’ and biofilm-embedded chronic wound bacteria. Scand J Infect Dis 41(5):341–347

    Article  PubMed  Google Scholar 

  41. Khalid KA, da Silva JAT (2012) Biology of Calendula officinalis Linn: focus on pharmacology, biological activities and agronomic practices. Med Aromat Plant Sci and Biotechnol 6(1):12–27

    Google Scholar 

  42. Muley BP, Khadabadi SS, Banarase NB (2009) Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): A Review. Trop J Pharm Res 8(5):455–465

    Article  CAS  Google Scholar 

  43. Cosmetic Ingredient Review Expert Panel (2001) Final report on the safety assessment of Calendula extract and C. officinalis. Int J Toxicol 20(Suppl 2):13–20

    Google Scholar 

  44. Andersen FA, Bergfeld WF, Belsito DV et al (2010) Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis derived cosmetic ingredients. Int J Toxicol 29(Suppl 4):221S–243S

    Article  CAS  PubMed  Google Scholar 

  45. Adedapo AA, Jimoh FO, Koduru S et al (2009) Assessment of the medicinal potentials of the methanol extracts of the leaves and stems of Buddleja saligna. BMC Complement Altern Med 9(1):21

    Article  PubMed  PubMed Central  Google Scholar 

  46. Sun M, Luo Z, Liu Y et al (2016) Identification of the major components of Buddleja officinalis extract and their metabolites in rat urine by UHPLC LTQ-Orbitrap. J Food Sc 81(10):H2587–H2596

    Article  CAS  Google Scholar 

  47. Quan-long W, Qing-hua P, Xiao-lei Y et al (2009) Effects of eye drops with extract of Buddleja officinalis on histo-morphology of lacrimal gland cells of castrated in rats with dry eyes. J Tradit Chin Med 5:007

    Google Scholar 

  48. Collee JG, Miles RS, Watt B (1996) Tests for the identification of bacteria, 14th edn. Churchill livingstone, New York

    Google Scholar 

  49. Paibon W, Yimnoi C-A, Tembab N et al (2011) Comparison and evaluation of volatile oils from three different extraction methods for some Thai fragrant flowers. Int J Cosmet Sci 33:150–156

    Article  CAS  PubMed  Google Scholar 

  50. Roopashree TS, Dang R, Shobha RH et al (2008) Antibacterial activity of antipsoriatic herbs: Cassia tora, Momordica charantia and Calendula officinalis. Int J of Appl Res Nat Prod 3:20–28

    Google Scholar 

  51. Christensen GD, Simpson WA, Younger JJ et al (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22(6):996–1006

    CAS  PubMed  PubMed Central  Google Scholar 

  52. CLSI (2014) Performance standards for antimicrobial disk susceptibility. tests Twenty-third informational supplement. CLSI document M100-S23. Clinical and laboratory standards Institute, Wayne

    Google Scholar 

  53. Yukinobu O, Shinichiro K, Akiyoshi T (2006) Biofilm formation by Staphylococcus epidermidis on intraocular lens material. Invest Ophthalmol Vis Sci 47:2971–2975

    Article  Google Scholar 

Download references

Authors’ contributions

AME designed experiments, interpreted data, wrote the manuscript and perform the submission process, GHS designed the study and revised manuscript, AAA analysed data and revised manuscript, HE performed experiments and interpreted data. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Authors and Affiliations

  1. Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt

    Amira M. El-Ganiny, Ghada H. Shaker & Heba A. El-Dash

  2. Microbiology and Immunology Department, Faculty of Medicine, Benha University, Benha, Egypt

    Abeer A. Aboelazm

Authors
  1. Amira M. El-Ganiny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ghada H. Shaker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abeer A. Aboelazm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heba A. El-Dash
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amira M. El-Ganiny.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Ganiny, A.M., Shaker, G.H., Aboelazm, A.A. et al. Prevention of Bacterial Biofilm Formation on Soft Contact Lenses Using Natural Compounds. J Ophthal Inflamm Infect 7, 11 (2017). https://doi.org/10.1186/s12348-017-0129-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12348-017-0129-0

Keywords